This post is from a suggested group
Managing Cellular Stress with Proteasome-Targeting Drugs
Proteasome inhibition introduces controlled cellular stress, pushing diseased cells beyond their survival threshold. This stress affects multiple systems simultaneously, making resistance more difficult.
Cells attempt to compensate by activating alternative degradation pathways, such as autophagy. However, prolonged proteasome blockade overwhelms these backup systems.
This multi-level stress response is a key reason why ubiquitin proteasome drugs remain effective in challenging disease settings.